However, there is also evidence that TEVs are taken up by melanoma and bladder cancer cells inhibiting apoptosis and favoring cell proliferation by targeting mitochondria through the regulation of the Bax/Bcl-2 signaling pathway [102,103]. This evidence concerns the gene BCL2 and melanoma.